PERIPHERAL NEUROPATHY
Clinical trials for PERIPHERAL NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL NEUROPATHY trials appear
Sign up with your email to follow new studies for PERIPHERAL NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can silicone pads replace foam to stop diabetic foot ulcers?
Disease control Not yet recruitingThis study compares silicone pads to felted foam for reducing pressure under the foot in people with diabetes and nerve damage who are at high risk of foot ulcers. About 80 participants will wear each type of pad, and researchers will measure how well they lower pressure and how …
Matched conditions: PERIPHERAL NEUROPATHY
Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Allergy pill may shield breast cancer patients from chemo nerve pain
Prevention Not yet recruitingThis study tests whether desloratadine, a common allergy medication, can prevent or reduce nerve damage (peripheral neuropathy) caused by taxane chemotherapy in breast cancer patients. About 116 people will receive either desloratadine or a placebo during their 12-week chemo cour…
Matched conditions: PERIPHERAL NEUROPATHY
Phase: PHASE2 • Sponsor: Montefiore Medical Center • Aim: Prevention
Last updated May 26, 2026 04:14 UTC
-
Simple exercises may ease chemo nerve pain
Symptom relief Not yet recruitingThis study tests whether a 15-minute hand and foot exercise routine can reduce nerve pain, numbness, and tingling caused by chemotherapy in cancer patients. 58 adults aged 20-60 with mild nerve damage will either receive standard care or standard care plus the exercise program. R…
Matched conditions: PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: University of Health Sciences Lahore • Aim: Symptom relief
Last updated May 26, 2026 04:18 UTC
-
New hope for diabetic nerve pain: 28-Day supplement trial launches
Symptom relief Not yet recruitingThis study tests whether an oral supplement called DLBS1033 can improve nerve damage symptoms in adults with type 2 diabetes. Over 28 days, 34 participants will receive either the supplement plus standard care or standard care alone. Researchers will measure changes in nerve func…
Matched conditions: PERIPHERAL NEUROPATHY
Phase: PHASE2, PHASE3 • Sponsor: Universitas Sebelas Maret • Aim: Symptom relief
Last updated May 26, 2026 04:16 UTC
-
Wearable gadget aims to steady steps for nerve damage patients
Symptom relief Not yet recruitingThis study tests a wearable device designed to improve balance and walking in adults with peripheral neuropathy (nerve damage). About 80 participants will use the device or a sham version for two months. The main goal is to see if the device safely improves gait and balance.
Matched conditions: PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: MYNERVA AG • Aim: Symptom relief
Last updated May 26, 2026 04:14 UTC
-
Simple hand and foot exercises may ease chemo nerve pain in older women
Symptom relief Not yet recruitingThis study looks at whether hand and foot exercises can reduce nerve damage (numbness, tingling) caused by chemotherapy in older adults with gynecological cancer. About 74 people aged 65 and older will take part. The goal is to see if these exercises improve quality of life and r…
Matched conditions: PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Symptom relief
Last updated May 18, 2026 12:02 UTC
-
Acupuncture and exercise may ease chemo nerve pain in bladder cancer
Symptom relief Not yet recruitingThis study tests whether adding acupuncture to virtual exercise can reduce nerve pain caused by chemotherapy in people with advanced bladder cancer. About 50 participants will either do acupuncture plus virtual exercise or just virtual exercise. The goal is to see if this combina…
Matched conditions: PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 18, 2026 11:59 UTC